1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Robert Abbott
Robert Abbott
Articles (879)  | Author's Website |

3 Dividend Stocks Gurus Like

Wells Faro, Pfizer and AbbVie all enjoy the confidence of several gurus

The Dividend Stocks screener at GuruFocus finds 616 dividend stocks held by the gurus as of the writing of this article. Another 19 are listed as over-the-counter stocks.

The output from the screener can be sorted in several ways. I've sorted by the largest number of gurus buys in the previous quarter. According to this search, Wells Fargo & Co (NYSE:WFC), Pfizer Inc (NYSE:PFE) and AbbVie Inc (NYSE:ABBV) are the most popular dividend stocks among gurus. In other words, these are the three companies with good dividends that had the highest number of guru buys in the quarter ended Sept. 30.

Wells Fargo

Altogether, 38 gurus hold positions in Wells Fargo, and during the third quarter, 19 bought while 17 sold. However, the sellers were moving more volume than the buyers:

Wells Fargo guru buys and sellsThe biggest stakes at quarter's end were held by:

The big news here is that Buffett no longer owns the biggest stake in the bank major after holding that position for years. As Sydnee Gatewood pointed out in her article, "Warren Buffett Continues to Cash Out of Wells Fargo," there are several possible reasons for the guru's exit. Those possibilities include a lack of capital gains despite many years of ownership - his average cost per share was about $24 and that was where the share price was in 2017. At the close of trading on Nov. 20, the price was $25.48.

Gatewood also noted that Buffett was unhappy about management's response to the false accounts scandal that became public in 2016 and continues to drag on. In his view, management made mistakes and shareholders are paying the price. The bad news and scandals that have engulfed Wells Fargo will cost shareholders billions of dollars.

However, so far, that hasn't affected the dividends per share. The current dividend yield is 4.79%, the dividend payout ratio is low at 4.18%, the three-year dividend growth rate is 8.20% and the five-year yield-on-cost is 6.47%.

Wells Fargo dividends per share chart


This pharmaceutical company has become a household name in recent weeks because it was the first U.S. firm to announce positive results for a vaccine for Covid-19. The next challenge for Pfizer will be to distribute the vaccine successfully because it must be stored at an extremely low temperature.

Twenty-four gurus had stakes in the drugmaker at the end of the third quarter. Of the gurus, 11 were buyers and 13 were sellers during the quarter. In this case, the buyers had an edge:

Pfizer guru buys and sellsThe three biggest holdings were those of:

This GuruFocus table below shows the dividend data for Pfizer:

Pfizer dividend table

It has steadily increased its dividend payments over the years:

Pfizer dividends per share chart


Like Pfizer, AbbVie is a drug company. It is best known for HUMIRA (adalimumab). The North Chicago, Illinois-based firm has specialized in immunology and oncology products but recently acquired another drugmaker, Allergan. That purchase diversifies AbbVie, with new interests in medical aesthetics, women's health and eye care.

This is a relatively young company that has grown rapidly since being spun off from Abbott Laboratories (NYSE:ABT) in 2013. Despite having only an eight-year history so far, it is building a reputation as a dividend stock.

In its annual report for 2019, the company observed:

"A growing dividend is an enduring hallmark of AbbVie's investment identity and in 2019, we increased our quarterly cash dividend 10 percent to $1.18 per share. Since our inception, we have increased our dividend by 195 percent and have been a member of the S&P Dividend Aristocrat Index since 2013."

Clearly, the dividend is a major part of its strategy to attract and keep investors. As this dividend table shows, it also rewards shareholders through share repurchases:

AbbVie Dividend Table

The following chart shows consistent growth in the dividend payment:

AbbVie dividends per share chart

At the end of the third quarter, the stock was owned by 23 of the gurus and they have been buying more than they have been selling for almost two years:

AbbVie guru buys and sellsThe top three positions on Sept. 30 were held by:


If you want to invest in dividend stocks, the activity of the investing gurus can help. It never hurts to look at the trades of the best investors. As always, investors should do their own due diligence to ensure they are getting quality companies in addition to above-average dividend yields.

Disclosure: I do not own shares in any of the companies named in this article.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

About the author:

Robert Abbott
Robert F. Abbott has been investing his family’s accounts since 1995 and in 2010 added options -- mainly covered calls and collars with long stocks.

He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors (whatisamutualfund.com).

As a writer and publisher, Abbott also explores how the middle class has come to own big business through pension funds and mutual funds, what management guru Peter Drucker called the "unseen revolution."

Visit Robert Abbott's Website

Rating: 5.0/5 (1 vote)



Please leave your comment:

Performances of the stocks mentioned by Robert Abbott

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)